<DOC>
	<DOCNO>NCT00840476</DOCNO>
	<brief_summary>The objective study compare rate extent absorption meloxicam test formulation Meloxicam 15 mg Tablets versus reference Mobic® 15 mg Tablets fast condition .</brief_summary>
	<brief_title>Meloxicam 15 mg Tablets Under Fasting Conditions</brief_title>
	<detailed_description>Criteria Evaluation : FDA Bioequivalence Criteria Statistical Methods : FDA bioequivalence statistical method</detailed_description>
	<mesh_term>Meloxicam</mesh_term>
	<criteria>Nonsmoking male female minimum age 18 year ( i.e . nonsmoker non tobacco user least 90 day prior prestudy medical ) . Body mass Index ( BMI = weight/height² ) great equal 18.5 kg/m² less equal 29.9 kg/m² . Availability subject entire study period willingness adhere protocol requirement , evidence sign Informed Consent Form . Normal finding physical examination , 12lead ECG vital sign ( blood pressure 100140/6090 mmHg , heart rate 5099 beats/min , temperature 35.8ºC 37.5ºC ) . Negative drug abuse , nicotine , alcohol , hepatitis Bsurface antigen , hepatitis C HIV , female subject , pregnancy ( serum ßCG ) . No clinical laboratory value outside acceptable range define BCR , unless Principal Investigator decide clinically significant . Female subject surgically sterile least six month postmenopausal least one year , avoid pregnancy prior study , study one month end study . Known history hypersensitivity meloxicam ( example Mobic® ) , relate drug nonsteroidal antiinflammatory drug ( NSAID ) acetylsalicyclic acid ( e.g . Excedrin® , Aspirin® ) , ibuprofen ( e.g . Motrin® ) , celecoxib ( e.g . Celebrex® ) , Feldene® , Indocin® , Naprosyn® , Vioxx® , Toradol® , Clinoril® , Tolectin® , Lodine® . Known history presence cardiac , pulmonary , gastrointestinal , endocrine , musculoskeletal , neurological , hematological , liver disease , unless judge clinically significant Principal Investigator , medical designate . Any history presence peptic ulcer disease , gastrointestinal bleeding , kidney disease . Known history presence food allergy , condition know interfere absorption , distribution , metabolism excretion drug . Any clinically significant illness last four week prior entry study . Presence significant physical organ abnormality . Any subject history drug abuse . Any psychiatric psychological disease ( include depression ) unless deem clinically significant Principal Investigator , medical designate . Use prescription medication within 14 day precede entry study . Use overthecounter ( OTC ) medication within seven day precede entry study ( except spermicidal/barrier contraceptive product ) . Female subject : use oral contraceptive contraceptive implant ( Norplant® ) within 30 day prior drug administration depot injection progestogen drug ( e.g . DepoProvera® ) within one year prior drug administration . Female subject : presence pregnancy lactation . Female subject risk become pregnant must consent use two medically acceptable method contraception throughout entire study , include washout period one month completion study . Medically acceptable barrier method contraception may use subject and/or partner include diaphragm spermicide , IUD , condom foam , vaginal spermicidal suppository . Complete abstinence use alone method contraception . Any subject blood drawn within 56 day precede study , take conduct clinical study facility BCR within lockout period specify previous study conduct BCR . Participation clinical trial investigational drug within 30 day precede study . Any subject donate blood within 56 day precede study . Any subject participate plasma donor plasmapheresis program within seven day precede study . Any subject recent ( less one year ) history alcohol abuse . Significant recent history asthma ( 12 year age ) , familial history asthma aspirinsensitive asthma , sever bronchospasm , nasal polyp chronic sinusitis . Intolerance venipuncture .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Bioequivalence</keyword>
	<keyword>Healthy Subjects</keyword>
</DOC>